SHIRI ET AL.
9 of 10
4.10.5
(2 h)
|
2‐(3‐Nitrophenyl)‐2,3‐dihydroquinazolin‐4(1H)‐one
32.6, 36.6, 50.6, 59.6, 103.5, 109.9, 121.5, 127, 129, 130.6,
130.9, 146.1, 150.3, 150.7, 167, 194.8.
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 5.98 (s, 1H), 6.72
(t, J = 8 Hz, 1H, Ar‐H), 6.82 (d, J = 8 Hz, 1H, Ar‐H), 7.29
(td, J = 6.8, 1.6 Hz, 1H, Ar‐H), 7.38 (brs, 1H, N─H),
7.65 (dd, J = 8, 1.6 Hz, 1H, Ar‐H), 7.71 (t, J = 8 Hz, 1H,
Ar‐H), 7.97 (d, J = 7.6 Hz, 1H, Ar‐H), 8.23 (dq, J = 8,
1.6 Hz, 1H, Ar‐H), 8.39 (t, J = 2 Hz, 1H, Ar‐H), 8.57
(brs, 1H, N─H). 13C NMR (100 MHz, DMSO‐d6, δC,
ppm): 65.7, 115.1, 115.4, 118, 122.1, 123.8, 127.9, 130.5,
133.8, 134.1, 144.7, 147.8, 148.2, 163.9.
4.10.10
| 2‐(4‐Chlorobenzylidene)malononitrile (6a)
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 7.74 (d, J = 8.8 Hz,
2H), 7.97 (d, J = 8.8 Hz, 2H), 8.73 (s, 1H). 13C NMR
(100 MHz, DMSO‐d6, δC, ppm): 82.7, 113.5 (CN), 114.5
(CN), 115.7 (2C), 130.5, 132.6 (2C), 139.5, 160.6.
4.10.11
| 2‐(4‐Methoxybenzylidene)malononitrile (6b)
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 7.21 (d, J = 7.2 Hz,
2H), 7.99 (d, J = 7.2 Hz, 2H), 8.41 (s, 1H). 13C NMR
(100 MHz, DMSO‐d6, δC, ppm): 56.4, 114.4 (CN), 115.3
(CN), 115.7 (2C), 124.6, 133.8 (2C), 160.9, 164.8.
4.10.6
| Ethyl‐4‐(4‐fluorophenyl)‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,
6,7,8‐hexahydroquinoline‐3‐carboxylate (4c)
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 0.85 (s, 3H), 1.02
(s, 3H), 1.13 (t, J = 7.2 Hz, 3H), 1.99 (d, J = 16 Hz, 1H),
2.18 (d, J = 16 Hz, 1H), 2.28–2.32 (m, 4H), 2.43
(d, J = 16.8 Hz, 1H), 3.98 (q, J = 7.2 Hz, 2H), 4.87 (s,
1H), 6.99–7.20 (m, 4H, Ar‐H), 9.11 (brs, 1H, N─H). 13C
NMR (100 MHz, DMSO‐d6, δC, ppm): 14.6, 18.8, 26.7,
29.6, 32.6, 35.8, 50.7, 59.5, 103.9, 110.4, 114.7, 129.6,
144.3, 145.7, 149.95, 159.7, 167.2, 194.7.
4.10.12
| 2‐(4‐Ethoxybenzylidene)malononitrile (6 h)
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 1.37 (t, J = 7.2 Hz,
3H), 4.19 (q, J = 7.2 Hz, 2H), 7.19 (d, J = 9.2 Hz, 2H), 7.98
(d, J = 9.2 Hz, 2H), 8.41 (s, 1H). 13C NMR (100 MHz,
DMSO‐d6, δC, ppm): 14.8, 64.5, 77.1, 114.4 (CN), 115.3
(CN), 116 (2C), 124.5, 133.9 (2C), 160.9, 164.2.
4.10.13
(6n)
| Ethyl (E)‐2‐cyano‐3‐(4‐methylphenyl)‐2‐propenoate
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 1.26 (t, J = 7.2 Hz,
3H), 2.4 (s, 3H), 3.54 (q, J = 7.2 Hz, 2H), 7.1 (d, J = 8 Hz,
2H), 7.45–7.47 (d, J = 8 Hz, 2H), 8.03 (s, 1H). 13C NMR
(100 MHz, DMSO‐d6, δC, ppm): 15.24 (CH3), 55.31
(CH3O), 65.39 (O─CH2), 102.33 (C─CN), 113.77 (CN),
121.36, 126.51, 132.22, 139.33, 152.57, 162.26 (C═O).
4.10.7
| Ethyl‐4‐(4‐bromophenyl)‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,
6,7,8‐hexahydroquinoline‐3‐carboxylate (4e)
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 0.85 (s, 3H), 1.02
(s, 3H), 1.13 (t, J = 7.2 Hz, 3H), 1.99 (d, J = 16 Hz, 1H), 2.18
(d, J = 16 Hz, 1H), 2.27–2.31 (m, 4H), 2.43 (d, J = 17.2 Hz,
1H), 3.98 (q, J = 7.2 Hz, 2H), 4.85 (s, 1H), 7.11–7.14 (m, 2H,
Ar‐H), 7.38–7.41 (m, 2H, Ar‐H), 9.13 (brs, 1H, N─H). 13C
NMR (100 MHz, DMSO‐d6, δC, ppm): 14.6, 18.8, 26.9,
29.6, 32.6, 36.2, 50.6, 59.6, 103.5, 110.1, 119.19, 130.2,
131.1, 145.9, 147.5, 150.1, 167.1, 194.7.
ACKNOWLEDGEMENT
This work was supported by the research facilities of Ilam
University, Ilam, Iran.
REFERENCES
4.10.8
| Ethyl‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,6,7,8‐hexahydro-
[1] A. Ghorbani‐Choghamarani, P. Zamani, J. Iran. Chem. Soc. 2012, 9, 607.
[2] A. Ghorbani‐Choghamarani, M. Norouzi, J. Mol. Catal. A. 2014, 395, 172.
[3] M. Saha, A. K. Pal, Tetrahedron. Lett. 2011, 52, 4872.
quinoline‐3‐carboxylate (4 h)
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 0.86 (s, 3H), 1.02
(s, 3H), 1.14 (t, J = 7.2 Hz, 3H), 1.99 (d, J = 16 Hz, 1H),
2.18 (d, J = 16 Hz, 1H), 2.29–2.33 (m, 4H), 2.44
(d, J = 17.2 Hz, 1H), 3.99 (q, J = 7.2 Hz, 2H), 4.88
(s, 1H), 7.06–7.21 (m, 5H, Ar‐H), 9.07 (brs, 1H, N─H).
13C NMR (100 MHz, DMSO‐d6, δC, ppm): 14.6, 18.8,
26.9, 29.6, 32.6, 36.4, 50.7, 59.5, 104.1, 110.5, 126.1,
127.9, 128.145.5, 148.1, 150, 167.3, 194.7.
[4] K. A. Undale, T. S. Shaikh, D. S. Gaikwad, D. M. Pore, C. R. Chim. 2011,
14, 511.
[5] J. Safari, S. Gandomi‐Ravandi, C. R. Chim. 2013, 16, 1158.
[6] A. Rostami, A. Tavakoli, Chin. Chem. Lett. 2011, 22, 1317.
[7] A. Ghorbani‐Choghamarani, G. Azadi, RSC. Adv. 2015, 5, 9752.
[8] K. Sirisha, G. Achaiah, V. M. Reddy, Arch. Pharm. 2010, 343, 342.
[9] J. L. Donelson, R. A. Gibbs, S. K. De, J. Mol. Catal. A. 2006, 256, 309.
[10] A. Heydari, S. Khaksar, M. Tajbakhsh, H. R. Bijanzadeh, J. Fluorine. Chem.
2009, 130, 609.
4.10.9
| Ethyl‐4‐(3‐bromophenyl)‐2,7,7‐trimethyl‐5‐oxo‐1,4,5,
6,7,8‐hexahydroquinoline‐3‐carboxylate (4i)
[11] A. Shaabani, A. Maleki, H. Mofakham, Synth. Commun. 2008, 38, 3751.
[12] L. Y. Zeng, C. J. Cai, J. Heterocycl. Chem. 2010, 47, 1035.
[13] J. X. Chen, W. K. Su, H. Y. Wu, M. C. Liu, C. Jin, Green. Chem. 2007, 9, 972.
[14] S. J. Ji, Z. Q. Jiang, J. Lu, T. P. Loh, Synlett. 2004, 831.
1H NMR (400 MHz, DMSO‐d6, δH, ppm): 0.87 (s, 3H), 1.03
(s, 3H), 1.14 (t, J = 7.2 Hz, 3H), 2.01 (d, J = 16 Hz, 1H),
2.19 (d, J = 16 Hz, 1H), 2.31–2.34 (m, 4H), 2.45
(d, J = 17.2 Hz, 1H), 4.0 (q, J = 7.2 Hz, 2H), 4.85 (s, 1H),
7.15–7.31 (m, 4H, Ar‐H), 9.16 (brs, 1H, N─H). 13C NMR
(100 MHz, DMSO‐d6, δC, ppm): 14.6, 18.8, 26.8, 29.6,
[15] M. Rueping, A. P. Antonchick, E. Sugiono, K. Grenader, Angew. Chem. Int.
Ed. 2009, 48, 908.
[16] X. Cheng, S. K. Vellalath, R. Goddard, J. Am. Chem. Soc. 2008, 130, 15786.